ACT Wealth Management LLC Invests $285,000 in UnitedHealth Group Incorporated $UNH

Key Points

• ACT Wealth Management LLC invested $285,000 in UnitedHealth Group, acquiring 912 shares of the company during Q2.
• UnitedHealth Group reported Q2 earnings of $4.08 per share, falling short of analysts' expectations of $4.45, with revenue reaching $111.62 billion.
• The company declared a quarterly dividend of $2.21, with an annualized dividend yielding 2.5% and a payout ratio of 38.30%.

ACT Wealth Management LLC acquired a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 912 shares of the healthcare conglomerate's stock, valued at approximately $285,000.

A number of other institutional investors have also modified their holdings of the business. IAM Advisory LLC increased its holdings in shares of UnitedHealth Group by 3.9% in the 2nd quarter. IAM Advisory LLC now owns 3,824 shares of the healthcare conglomerate's stock valued at $1,193,000 after acquiring an additional 145 shares during the period. Everpar Advisors LLC increased its holdings in shares of UnitedHealth Group by 29.4% in the 2nd quarter. Everpar Advisors LLC now owns 1,167 shares of the healthcare conglomerate's stock valued at $364,000 after acquiring an additional 265 shares during the period. Next Level Private LLC grew its position in UnitedHealth Group by 163.8% in the 2nd quarter. Next Level Private LLC now owns 1,021 shares of the healthcare conglomerate's stock valued at $319,000 after buying an additional 634 shares during the last quarter. Dover Advisors LLC grew its position in UnitedHealth Group by 0.6% in the 2nd quarter. Dover Advisors LLC now owns 5,999 shares of the healthcare conglomerate's stock valued at $1,872,000 after buying an additional 37 shares during the last quarter. Finally, Chemistry Wealth Management LLC grew its position in UnitedHealth Group by 24.0% in the 2nd quarter. Chemistry Wealth Management LLC now owns 10,177 shares of the healthcare conglomerate's stock valued at $3,175,000 after buying an additional 1,970 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Price Performance

NYSE:UNH opened at $348.05 on Tuesday. The firm has a market cap of $315.22 billion, a price-to-earnings ratio of 15.08, a price-to-earnings-growth ratio of 2.30 and a beta of 0.44. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $630.73. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The company's 50-day moving average is $292.87 and its two-hundred day moving average is $367.43.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). The company had revenue of $111.62 billion for the quarter, compared to analysts' expectations of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company's revenue was up 12.9% on a year-over-year basis. During the same quarter in the previous year, the company earned $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be issued a $2.21 dividend. The ex-dividend date is Monday, September 15th. This represents a $8.84 annualized dividend and a yield of 2.5%. UnitedHealth Group's dividend payout ratio (DPR) is presently 38.30%.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on UNH shares. Truist Financial lifted their price objective on shares of UnitedHealth Group from $310.00 to $365.00 and gave the company a "buy" rating in a research report on Tuesday, September 9th. Wells Fargo & Company lowered their price objective on shares of UnitedHealth Group from $306.00 to $267.00 and set an "overweight" rating on the stock in a research report on Monday, August 4th. Hsbc Global Res cut shares of UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a research note on Wednesday, May 21st. Wall Street Zen cut shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Saturday, May 24th. Finally, Robert W. Baird reaffirmed an "underperform" rating and set a $198.00 price target (down from $312.00) on shares of UnitedHealth Group in a research note on Thursday, July 31st. Sixteen research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of "Moderate Buy" and a consensus target price of $358.95.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.